Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not
Condition:   Breast CancerInterventions:   Drug: Tamoxifen,;   Drug: Exemestane;   Drug: Anastrozole;   Drug: LetrozoleSponsors:   Institut Claudius Regaud;   Institut Claudius RegaudCompleted - verified June 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2011 Category: Research Source Type: clinical trials

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy
Condition:   Breast CancerInterventions:   Other: questionnaire administration;   Drug: fluocinonide cream;   Procedure: management of therapy complicationsSponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)Recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2011 Category: Research Source Type: clinical trials

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy
Condition:   Breast CarcinomaInterventions:   Drug: Fluocinonide Cream;   Procedure: Management of Therapy Complications;   Other: Questionnaire AdministrationSponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2011 Category: Research Source Type: clinical trials

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Condition:   Prostate CancerInterventions:   Drug: Cabazitaxel;   Radiation: Intensity Modulated Radiation Therapy (IMRT);   Drug: Anti-Androgen Therapy: Bicalutamide;   Genetic: Luteinizing Hormone-Releasing Hormone (LHRH) AgonistSponsors:   Thomas Jefferson University;   SanofiRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2011 Category: Research Source Type: clinical trials

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Condition:   Prostate CancerInterventions:   Other: Brachytherapy + Decapeptyl® SR 22.5mg Triptorelin;   Radiation: BrachytherapySponsor:   IpsenActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2011 Category: Research Source Type: clinical trials

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Condition:   Prostate CancerInterventions:   Other: Brachytherapy + Decapeptyl® SR 22.5mg Triptorelin;   Radiation: BrachytherapySponsor:   IpsenTerminated - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 14, 2011 Category: Research Source Type: clinical trials

HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy
Condition:   Breast CancerIntervention:   Biological: Hu3S193Sponsors:   Instituto do Cancer do Estado de São Paulo;   Fundação Faculdade de Medicina;   Recepta BiopharmaRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2011 Category: Research Source Type: clinical trials

S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
Condition:   Prostate CancerInterventions:   Drug: abiraterone acetate;   Drug: degarelix;   Drug: leuprolide acetate;   Procedure: orchiectomySponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)Active, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2011 Category: Research Source Type: clinical trials

A Study to Test if MDV3100 is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Condition:   Prostate CancerIntervention:   Drug: MDV3100Sponsors:   Astellas Pharma Inc;   Medivation, Inc.Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2011 Category: Research Source Type: clinical trials

A Study to Test if MDV3100 is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Condition:   Prostate CancerIntervention:   Drug: MDV3100Sponsors:   Astellas Pharma Inc;   Medivation, Inc.Active, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2011 Category: Research Source Type: clinical trials

A Study to Test if MDV3100 is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Condition:   Prostate CancerIntervention:   Drug: MDV3100Sponsors:   Astellas Pharma Inc;   Medivation, Inc.Active, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2011 Category: Research Source Type: clinical trials